Gordon Stephen 4
4 · TransMedics Group, Inc. · Filed May 8, 2024
Insider Transaction Report
Form 4
Gordon Stephen
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-05-06$128.00/sh−15,000$1,920,000→ 23,299 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-06−15,000→ 22,477 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-05-06$38.46/sh+15,000$576,900→ 38,299 total
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
- [F2]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.